Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
alnylam pharmaceuticals
boston
boston blog main
boston top stories
fda
hereditary transthyretin amyloidosis
life sciences
national blog main
national top stories
patisiran
akcea therapeutics
alexion pharmaceuticals
biology
biotech
boehringer ingelheim
clinical trials
computerscience
deals
dicerna pharamceuticals
drugdevelopment
drugs
european medicines agency
harvard pilgrim health care
hepatitis b
hepatitis b virus
inotersen
institute for clinical and economic review
machinelearning
medicine
new york blog main
new york top stories
onpattro
pfizer
rna interference
roche
san diego blog main
san diego top stories
tafamidis
world health organization
What
drug
3
×
protein
3
×
gene
alnylam
applications
approves
caught
causing
cells
design
dicerna
disease
ema
employ
europe
eye
fda
follows
harmful
hepatitis
hits
improve
intended
interference
make
medicine
medicines
method
mute
new
pay
pharma
pharmaceuticals
producing
research
rna
rnai
roche
stop
tasks
Language
unset
Current search:
protein
×
drug
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@SwissCognitive
5 years ago
This new technique could improve #MachineLearning tasks in protein design, drug testing, and other applications. #ComputerScience #Biology #Medicine #DrugDevelopment http://ow.ly/mtWx30oaNav
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
